Browsing Tag
NASDAQ
289 posts
CLPS Incorporation reveals fiscal 2024 results amid global expansion strategy
CLPS Incorporation has reported its financial outcomes for the second half and the full fiscal year of 2024.…
MetroCity Bankshares posts strong Q3 2024 performance despite slight dip in profits
MetroCity Bankshares, Inc., the holding company for Metro City Bank, has revealed its financial performance for Q3 2024.…
Parke Bancorp reports strong Q3 2024 earnings, driven by loan growth and cost management
Parke Bancorp, Inc. reported a significant net income increase of $7.5 million for Q3 2024, a 16.3% rise…
Can MetroCity Bankshares bounce back? Q3 2024 results reveal slight profit slip
MetroCity Bankshares, Inc. (NASDAQ: MCBS), the holding company for Metro City Bank, has disclosed its financial performance for…
Home Bancorp Inc’s shocking Q3 surge: Profits soar and dividend boosted by 4%—Investors rejoice
Home Bancorp, Inc. (Nasdaq: “HBCP”), the parent company of Home Bank, N.A., has reported robust financial results for…
Virginia National Bankshares Corporation’s Q3 2024 earnings: A mixed bag of performance and strategic growth
Virginia National Bankshares Corporation, trading on NASDAQ under the symbol VABK, has reported its earnings for the third…
Samfine Creation stock soars 37% in shocking Nasdaq debut—What’s behind the surge?
Samfine Creation Holdings Group Limited made a sensational debut on the Nasdaq, with its shares skyrocketing by 37%…
Ceribell’s stock surges 36% in blockbuster trading debut: AI seizure tech takes Wall Street by storm
In a sensational opening on Wall Street, Ceribell’s stock surged by 36% in its trading debut, reflecting immense…
AGBA shares surge 28% as $4bn merger with Triller nears completion
AGBA Group Holding Limited (NASDAQ: AGBA) saw a significant 28% rise in its stock price, riding on the…
Biotech stocks in trouble? Immatics shares plunge after $150m funding news shocks investors
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company focused on cancer immunotherapies, has seen its shares decline significantly…